CClinicalTrials.gg
Status unknownNCT04626544Updated May 9, 2023

Dynamic Neck Function During Gait in Patients With Dizziness

An observational study in Dizziness, Neck Pain and Gait, sponsored by Haukeland University Hospital. Status unknown at 1 site in Norway. Open to participants aged 18 Years to 67 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-09.

Sponsored by Haukeland University Hospital · Observational

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
110
Ages
18 Years to 67 Years
Sex
All
01

Study summary

This study aims to explore the possible association between dizziness and head-on trunk-movements and thus, neck movement and if this differs to healthy controls. Additional, the study will examine the reliability and validity of using wearable accelerometers to examine how the head moves relative to the trunk and to collect normative data on head on trunk movement.

Read the detailed description

Patients with dizziness will be recruited from a ear-nose and throat clinic. After giving written consent the patients will be tested with wearable sensors on their occiput and C6 vertebra during gait. Healthy controls will be recruited from students and employees at the Western Norway University of Applied Science and go through the same protocol as the patients.

The investigators will measure the relationship between the two sensors to explore how patients with dizziness move their-on-trunk during gait.

The projects main hypothesis is that patient with dizziness have reduced attenuation of gait-associated head oscillations with increased coupling of head-on-trunk motion, compared to healthy controls. The neck does not compensate for trunk movements, causing the head to follow the movement of the trunk.

02

Conditions studied

  • Dizziness
  • Neck Pain
  • Gait
03

In context

Vertigo

248 studies on the registry are indexed under Vertigo; 39 are open to participants now.

This study's planned enrollment of 110 is below the median of 151 across 50 observational studies indexed under Vertigo.

Browse Vertigo studies →

Lead sponsor

Haukeland University Hospital is the lead sponsor of 276 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Consecutive patients with dizziness between the ages of 18 - 70 will be recruited from the ear-nose-and throat (ENT) clinic at Haukeland University Hospital (HUS). The clinic admits approximately 1200 patients yearly referred for dizziness and balance issues. All participants recruited form the ENT-clinic will be examined and diagnosed by an otorhinolaryngologist.

A group of healthy controls between the ages of 18 - 70 will be recruited to generate normative data. A total of 10 participants of each gender will be recruited in the age groups 18 - 30, 31 - 50, 51 - 70. The participants have to be free of any vestibular symptoms and neck pain, going back the last three months, and they have to be free of any severe neurologic or orthopedic disease affecting gait.

Inclusion criteria

Locally referred Patients to an ear-nose-and throat (ENT) clinic at an University Hospital for dizziness symptoms.

Exclusion criteria

Exclusion Criteria:

Any severe neurologic or orthopedic disease affecting gait.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Dizziness

    Patients with dizziness referred to a secondary referral center

    Device: Body-worn inertial sensors

  • Healthy controls

    Healthy controls without dizziness or neck pain symptoms for the last 3 months

    Device: Body-worn inertial sensors

Interventions

  • DeviceBody-worn inertial sensors

    The device typically includes accelerometers that capture body accelerations in three directions (anteroposteriorly, mediolaterally and vertically) and gyrometers that capture rotations (yaw, pitch and roll). The method of measuring gait using body-worn inertial sensors has been found reliable \[15\] and valid \[20\]. This project will use Opal sensors and the Mobility Lab software from the manufacturer APDM (https://www.apdm.com/wearable-sensors/).

06

What researchers measure

Primary outcomes

  1. Accelerometer data (anteroposteriorly, mediolaterally and vertically) and gyrometer data (yaw, pitch and roll).

    The outcome is the difference/regression between the sensor placed on the participant head and the sensor placed on the participants C6 vertebra. The method of measuring gait using body-worn inertial sensors has been found reliable and valid. This project will use Opal sensors and the Mobility Lab software from the manufacturer APDM (https://www.apdm.com/wearable-sensors/).

    Time frame: Baseline

  2. Video analysis: Three-dimensional motion capture

    Three-dimensional motion capture is considered the gold standard of movement analysis. Using this method, reflective markers are placed on specified body landmarks. The subject is then filmed from different angles using several cameras, allowing for analysis of the markers relative to one another. Both rotation and acceleration is captured this way. The project will use an eight-camera system from Qualisys, with analyses performed using Visual 3D software.

    Time frame: Baseline

Secondary outcomes

  1. Dizziness Handicap Inventory (DHI)

    The severity of dizziness handicap will be evaluated using a Norwegian version of the Dizziness Handicap Inventory (DHI) \[24\]. This questionnaire aims to quantify the handicap experienced by dizziness. It contains 25 items with a maximum score of 100. A score \> 29 indicates disability. The Norwegian version of the questionnaire has been validated and the sum score demonstrates satisfactory measurement properties.

    Time frame: Baseline

  2. Neck Disability Index (NDI)

    The degree of neck disability will be measured with the Neck Disability Index (NDI) \[26\]. The NDI consists of 10 items with each score on a 0 to 5 rating scale and a total range of 0 - 50. Scores between 0-and 4 indicate no disability, 5-14 mild disability, 15-24 moderate disability, 25-34 severe disability and 35-50 complete disability \[26\]. The index has been validated in the evaluation of pain and disability in acute and chronic conditions. The Norwegian version has shown good test-retest reliability.

    Time frame: Baseline

  3. Vertigo symptom Scale - Short form

    To measure the degree of dizziness symptom severity, the Vertigo Symptom Scale - short form (VSSsf) will be used. The form comprise 15 items, and the patients answer how frequently they have experienced symptoms in the past month on a scale from 0-4, giving a range of score from 0 to 60. A higher score indicates increased symptom severity. A score ≥ 12 points on the total scale indicates severe dizziness. The total scale can be subdivided into two subscales measuring severity of autonomic symptoms, such as sweating, heart pounding and nausea, and severity of vertigo and balance symptoms. The questionnaire with its subscales has been validated into Norwegian.

    Time frame: Baseline

  4. Numeric pain rating scale (NPRS)

    Patients reporting neck pain will be asked to rate their neck pain during the two last weeks on an 11-point scale. The NPRS has previously shown adequate reliability and validity in patients with chronic pain conditions, including neck pain.The pain is rated from 0 to 10 where 0 represents no pain and 10 represents the worst imaginable pain.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Høgskulen på Vestlandet
    Bergen, Vestland, Norway
    • Mari Kalland Knapstad, PhD · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04626544
Lead sponsor
Haukeland University Hospital
Collaborators
Western Norway University of Applied Sciences
Responsible party
Sponsor
First posted
Nov 12, 2020
Start date
Jan 10, 2022
Primary completion
Jun 2024 (estimated)
Completion
Jun 2024 (estimated)
Last update
May 9, 2023

Study contacts

Mari Kalland Knapstad, PhD
Contact
mariknap@hotmail.com
+47 90524929
Frederik Kragerud Goplen, PhD
principal investigator · Haukeland University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion